---

View & Download the Key slides presented and developed by faculty members

Chronic Kidney Disease & Mineral Bone Disorder: What are the drivers of disease? Prof John Cunningham UCL Centre for Nephrology The Royal Free Hospital and UCL Medical School, London	Mechanisms of CKD-MBD: Mechanisms of CKD-MBD: New insights in the pathogenesis Jorge Cannata-Andia University of Oviedo Oviedo, Spain
Role of protein intake & phosphate levels CKD & Nutrition: Role of protein intake & phosphate levels Prof. Denis Fouque University of Lyon France	Protein energy wasting in CKD patients Protein energy wasting in CKD patients  Dr. Juan J. Carrero  Karolinska Institutet, Stockholm, Sweden
New evidence in the treatment of hyperphosphatemia New evidence in the treatment of hyperphosphatemia Prof Mario Gennaro Cozzolino University of Milan Italy	Chronic Kidney Disease & Cardiovascular Disease Chronic Kidney Disease & Cardiovascular Disease: A clinical update from KDIGO Eberhard Ritz University of Heidelberg Germany

---

View PACE talks with faculty members of the Renal Master Class

Each faculty member will provide in 5-10 minutes the key highlights of their presentation

Protein energy wasting in CKD patients Dr. Carrero (Stockholm, Sweden) gives an overview about the prevalence, pathophysiology, outcomes and monitoring of protein energy wasting.	Mechanisms of CKD-MBD: New insights in the pathogenesis Dr. Cannata-Andia (Oviedo, Spain) tells about the pathogenesis of CKD-MBD.
CKD & MBD: what are the drivers of disease? Prof. John Cunningham (London, United Kingdom) discusses what are the responses to a decrease of GFR on kidney disease and how these can be triggered.	CKD and CVD disease: a clinical update from KDIGO Prof. Ritz (Heidelberg, Germany) gives an overview about different cardiorenal syndromes
CKD & Nutrition: Role of protein intake & phosphate levels Prof. Denis Fouque (Lyon, France) discusses the role of protein intake on renal function and on phosphate levels.	New evidence in the treatment of hyperphosphatemia Dr. Cozzolino (Milan, Italy) discusses the role of phosphate binders in the treatment of hyperphosphatemia

---

CME Accreditation

The Renal Master Class was accredited by the European Accreditation Council for Continuing Medical Education (EACCME) for 7 CME hours and  by the European Board for Accreditation in Cardiology (EBAC) for 6 CME hours.
 

Financial support

This Renal Master Class was sponsored through an unrestricted educational grant provided by Shire Pharmaceuticals.

---

Educational objectives of the Renal Master Class were:

• To review the epidemiology of chronic kidney disease
• To explore the mechanisms that underlie the progression of chronic kidney disease
• To define the cornerstones of current treatment of chronic kidney disease
• To specify the needs of both dialysis and predialysis patients
• To define goals in the management of metabolic and electrolyte disturbances
• To define the adequate nutritional needs in the CKD patient
• To improve therapy adherence in patients with chronic kidney disease
• To develop a consensus on practical guidelines for day-to-day management of patients with chronic kidney disease to achieve the best attainable health status

---

Meeting highlights and educational resources

In this section, as an educational service, the presentations held during the Renal Master Class will be posted to view and download (with permissions of speakers). More uploads of presentations and expert opinions will follow in the upcoming weeks